MedPath

BAKTERA VOYAGE

BAKTERA VOYAGE

Discontinued
DIN Number

02248460

Drug Class

Human

Market Date

Apr 1, 2004

Company
HC

les laboratoires suisse inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02248460
AIG Number0349671001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A07FA01 LACTIC ACID PRODUCING ORGANISMS
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification56:08.00
Health Canada Classification

ACTIVE INGREDIENTS (3)

BIFIDOBACTERIUM LONGUMActive
Strength: 700000000 UNIT
Monograph: BIFIDOBACTERIUM LONGUM
LACTOBACILLUS ACIDOPHILUSActive
Strength: 1200000000 UNIT
Monograph: LACTOBACILLUS ACIDOPHILUS
LACTOBACILLUS CASEIActive
Strength: 100000000 UNIT
Monograph: LACTOBACILLUS CASEI

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.